Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFSV
2476
Dimensional US Small Cap Value ETF
DFSV
$8.46B
| $1.04M | ﹤0.01% |
+33,900
| New | +$1.07M |
|
|
SVC
2477
Service Properties Trust
SVC
$1.06B
| $1.04M | ﹤0.01% |
+81,760
| New | +$1.32M |
|
|
MDV
2478
Modiv Industrial
MDV
| $1.04M | ﹤0.01% |
69,600
-19,100
| -22% | -$310K |
|
2479
CPI Card Group
PMTS
$325M
| $1.03M | ﹤0.01% |
34,600
+26,808
| +344% | +$745K |
|
2480
Moog Inc Class B
MOG.B
| $1.03M | ﹤0.01% |
5,300
-500
| -9% | -$103K |
|
2481
Berkshire Hathaway Class B
BRK.B
$1.08T
| $1.03M | ﹤0.01% |
2,270
-220,245
| -99% | -$102M |
|
2482
Lyell Immunopharma
LYEL
$341M
| $1.03M | ﹤0.01% |
80,607
+70,737
| +717% | +$1.4M |
|
2483
Zumiez
ZUMZ
$316M
| $1.03M | ﹤0.01% |
53,811
+11,111
| +26% | +$237K |
|
2484
Schwab US Large- Cap ETF
SCHX
$74.8B
| $1.03M | ﹤0.01% |
+44,500
| New | +$1.04M |
|
|
2485
Microsoft
MSFT
$3.68T
| $1.03M | ﹤0.01% |
2,383
-1,568,888
| -100% | -$668M |
|
|
YMAB
2486
DELISTED
Y-mAbs Therapeutics
YMAB
| $1.03M | ﹤0.01% |
131,600
+103,700
| +372% | +$1.26M |
|
2487
Invesco Galaxy Bitcoin ETF
BTCO
$422M
| $1.03M | ﹤0.01% |
+11,000
| New | +$912K |
|
2488
LGL Group
LGL
$93.7M
| $1.03M | ﹤0.01% |
171,821
-5,900
| -3% | -$35.2K |
|
2489
Orion Energy Systems
OESX
$79M
| $1.02M | ﹤0.01% |
128,067
-4,979
| -4% | -$43.6K |
|
2490
EyePoint Inc
EYPT
$1.22B
| $1.02M | ﹤0.01% |
137,500
-49,937
| -27% | -$465K |
|
2491
Donnelley Financial Solutions
DFIN
$1.2B
| $1.02M | ﹤0.01% |
16,300
+12,500
| +329% | +$780K |
|
|
ALLK
2492
DELISTED
Allakos
ALLK
| $1.02M | ﹤0.01% |
844,233
+118,394
| +16% | +$124K |
|
|
GBIO
2493
DELISTED
Generation Bio
GBIO
| $1.02M | ﹤0.01% |
96,296
+36,866
| +62% | +$657K |
|
2494
HBT Financial
HBT
$1.35B
| $1.02M | ﹤0.01% |
46,600
-5,605
| -11% | -$128K |
|
|
WAY
2495
Waystar Holding Corp
WAY
$4.76B
| $1.02M | ﹤0.01% |
27,800
-133,200
| -83% | -$4.1M |
|
2496
iShares Core S&P US Value ETF
IUSV
$28B
| $1.02M | ﹤0.01% |
11,000
-16,500
| -60% | -$1.59M |
|
2497
Schwab Fundamental US Small Company Index ETF
FNDA
$9.44B
| $1.01M | ﹤0.01% |
+34,100
| New | +$1.04M |
|
|
SBT
2498
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $1.01M | ﹤0.01% |
212,074
-7,100
| -3% | -$33.6K |
|
2499
Lightbridge
LTBR
$315M
| $1.01M | ﹤0.01% |
212,600
+188,600
| +786% | +$1.13M |
|
2500
GlobalFoundries
GFS
$29.4B
| $1M | ﹤0.01% |
+23,400
| New | +$980K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.